- Home
- GOSS vs ORIS Comparison
GOSS vs ORIS Comparison
Compare GOSS & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- ORIS
- Stock Information
- Founded
- GOSS 2015
- ORIS 2014
- Country
- GOSS United States
- ORIS China
- Employees
- GOSS N/A
- ORIS N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- ORIS Farming/Seeds/Milling
- Sector
- GOSS Health Care
- ORIS Consumer Staples
- Exchange
- GOSS Nasdaq
- ORIS Nasdaq
- Market Cap
- GOSS 212.9M
- ORIS 182.0M
- IPO Year
- GOSS 2019
- ORIS 2024
- Fundamental
- Price
- GOSS $0.74
- ORIS $6.03
- Analyst Decision
- GOSS Strong Buy
- ORIS
- Analyst Count
- GOSS 5
- ORIS 0
- Target Price
- GOSS $9.20
- ORIS N/A
- AVG Volume (30 Days)
- GOSS 881.6K
- ORIS 241.5K
- Earning Date
- GOSS 11-07-2024
- ORIS 11-25-2024
- Dividend Yield
- GOSS N/A
- ORIS N/A
- EPS Growth
- GOSS N/A
- ORIS N/A
- EPS
- GOSS N/A
- ORIS 0.96
- Revenue
- GOSS $105,322,000.00
- ORIS $24,122,000.00
- Revenue This Year
- GOSS N/A
- ORIS N/A
- Revenue Next Year
- GOSS N/A
- ORIS N/A
- P/E Ratio
- GOSS N/A
- ORIS $6.29
- Revenue Growth
- GOSS N/A
- ORIS N/A
- 52 Week Low
- GOSS $0.50
- ORIS $4.80
- 52 Week High
- GOSS $1.60
- ORIS $11.75
- Technical
- Relative Strength Index (RSI)
- GOSS 22.63
- ORIS N/A
- Support Level
- GOSS $0.78
- ORIS N/A
- Resistance Level
- GOSS $0.92
- ORIS N/A
- Average True Range (ATR)
- GOSS 0.05
- ORIS 0.00
- MACD
- GOSS -0.01
- ORIS 0.00
- Stochastic Oscillator
- GOSS 0.00
- ORIS 0.00
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is a company who is an integrated supplier of tea products in Mainland China. Their major tea products include primarily-processed tea consisting of white tea and black tea, and refined white tea and black tea. Its business operations are vertically integrated, covering cultivation, processing of tea leaves and the sale of tea products to tea business operators (such as wholesale distributors) and end-user retail customers in Mainland China.